Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+136K
-
Total reported value, excl. options
-
$626M
-
Value change
-
+$5.81M
-
Put/Call ratio
-
0.57
-
Number of buys
-
41
-
Number of sells
-
-24
-
Price
-
$29.51
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q1 2019
76 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q1 2019.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 1.09B outstanding shares and own 1.94% of the company stock.
Largest 10 shareholders include FMR LLC (5.84M shares), Segantii Capital Management Ltd (2.4M shares), BAMCO INC /NY/ (2M shares), ORBIMED ADVISORS LLC (1.4M shares), CREDIT SUISSE AG/ (1.02M shares), VANGUARD GROUP INC (973K shares), GILDER GAGNON HOWE & CO LLC (903K shares), BlackRock Inc. (695K shares), Myriad Asset Management Ltd. (676K shares), and Tree Line Advisors (Hong Kong) Ltd. (525K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.